Menu

Flash News

Denmark pauses use of AstraZeneca vaccine over reports of blood clots

DR
Estimated read time: 1'

The Danish Medicines Agency decided, Thursday, to pause vaccinating with AstraZeneca. The decision comes after finding cases of blood clots shortly after vaccination, AFP reports.

«Serious cases of blood clots» have been reported in people vaccinated with this product. Denmark reports having recorded the death of a person who had received the vaccine. 

The Swedish agency stresses, however, that one «cannot conclude that there is a link between the vaccine and said blood clots». «It is important to emphasize that we have not opted out of the AstraZeneca vaccine, but that we are putting it on hold», Soren Brostrom, director of the National Board of Health in Denmark said.

«There is good evidence that the vaccine is both safe and effective.But both we and the Danish Medicines Agency have to react to reports of possible serious side effects, both from Denmark and other European countries».

Soren Brostrøm

Austria announced on Monday that it had stopped administering a batch of vaccines produced by the Swedish-British laboratory after the death of a 49-year-old nurse, who had succumbed to «serious bleeding disorders» a few days after receiving said vaccine.

Four other European countries (Estonia, Lithuania, Latvia and Luxembourg) immediately suspended vaccinations with doses from this batch, delivered to seventeen countries and which included one million vaccines.

Until March 9, twenty-two cases of thrombosis had been reported for more than three million people vaccinated in the European Economic Area, according to the European Medicines Agency.

However, the European Medicines Agency said on Thursday that the AstraZeneca vaccine can be used despite the investigation of blood clots.

Be the first one to comment on our articles...